Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by King Faisal Specialist Hospital & Research Center.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Dr. Naeem A. Chaudhri, King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT00541411
First received: October 9, 2007
Last updated: April 16, 2012
Last verified: April 2012

October 9, 2007
April 16, 2012
June 2003
June 2013   (final data collection date for primary outcome measure)
Efficacy [ Time Frame: overall ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00541411 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
Not Provided

Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Ewing's Sarcoma
Drug: Vincristine, Actinomycin-D, Ifosfamide
Chemotherapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
10
June 2013
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with Ewing's Sarcoma
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00541411
RAC#2031-065
Not Provided
Dr. Naeem A. Chaudhri, King Faisal Specialist Hospital & Research Center
King Faisal Specialist Hospital & Research Center
Not Provided
Principal Investigator: Muhammad Memon, MD King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
King Faisal Specialist Hospital & Research Center
April 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP